Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SHJ002 for Corneal Erosion in Sjogren's Syndrome
NCT06381986Phase 2Completed
- Sponsor
- Sunhawk Vision Biotech, Inc.
- Start
- Jun 2024
- Primary completion
- Apr 2025
- Modality
- Modified DNA Oligonucleotides, Single-strand DNA, Antisense Oligonucleotides (ASOs)
- Countries
- 1
01
Overview
A Phase 2 trial of SHJ002 in corneal erosion, sponsored by Sunhawk Vision Biotech, Inc.. Started Jun 2024; status: completed.
02
Drugs
SHJ002
03
Conditions
corneal erosion
Beyond the preview
Go deeper on NCT06381986.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06381986.